Log In
Print
BCIQ
Print
Print this Print this
 

MCItect

  Manage Alerts
Collapse Summary General Information
Company DiaGenic ASA
DescriptionBlood-based gene expression test for early Alzheimer's disease (AD) detection in the pre-dementia stage
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPivotal
Standard IndicationNeurology, Diagnostic
Indication DetailsPredict conversion to Alzheimer's disease (AD) in patients with amnestic mild cognitive impairment (MCI)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today